Literature DB >> 24788504

Monostotic fibrous dysplasia of the proximal femur: natural history and predisposing factors for disease progression.

I Han1, E S Choi, H-S Kim.   

Abstract

Monostotic fibrous dysplasia of the proximal femur has a variable clinical course, despite its reported limited tendency to progress. We investigated the natural history and predisposing factors for progression of dysplasia in a group of 76 patients with a mean follow-up of 8.5 years (2.0 to 15.2). Of these, 31 (41%) presented with an asymptomatic incidental lesion while 45 (59%) presented with pain or a pathological fracture. A group of 23 patients (30%) underwent early operative treatment for pain (19: 25%) or pathological fracture (4: 5%). Of the 53 patients who were initially treated non-operatively, 45 (85%) remained asymptomatic but eight (15%) needed surgery because of pain or fracture. The progression-free survival of the observation group was 81% (sd 6.4%) at five-years follow-up. An initial presentation of pain (p < 0.001), a limp (p < 0.001), radiological evidence of microfracture (p = 0.001) and younger age (< 17 years) (p = 0.016) were significant predisposing factors for disease progression. The risk of experiencing pain or pathological fracture is considerable in monostotic fibrous dysplasia of the proximal femur. Patients presenting with pain, a limp or radiological evidence of microfracture have a high chance of needing surgical treatment.

Entities:  

Keywords:  Fibrous dysplasia; Monostotic; Natural history; Pathologic fracture; Proximal femur

Mesh:

Year:  2014        PMID: 24788504     DOI: 10.1302/0301-620X.96B5.33281

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  7 in total

1.  Surgical strategy for benign lesions in proximal femur: internal fixation or endoprosthetic replacement.

Authors:  Hongyuan Liu; Xiang Fang; Zeping Yu; Yun Lang; Yan Xiong; Hong Duan
Journal:  Int Orthop       Date:  2018-04-17       Impact factor: 3.075

2.  Co-administration of Systemic and Intralesional Zoledronic Acid in a Case of Fibrous Dysplasia: A Potentially Novel Therapy.

Authors:  Sanjay Kumar Bhadada; Rimesh Pal; Ashwani Sood; Vandana Dhiman; Uttam Chand Saini
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-19       Impact factor: 5.555

3.  A Minimally Invasive Novel Technique Using a New Device to Treat Proximal Femoral Cystic Lesions.

Authors:  Akio Sakamoto; Takeshi Okamoto; Shuichi Matsuda
Journal:  J Orthop Case Rep       Date:  2020 May-Jun

4.  Clinicopathological and genetic study of a rare occurrence: Malignant transformation of fibrous dysplasia of the jaws.

Authors:  Ruirui Shi; Xuefen Li; Jianyun Zhang; Feng Chen; Ming Ma; Yanrui Feng; Tiejun Li
Journal:  Mol Genet Genomic Med       Date:  2022-01-05       Impact factor: 2.183

5.  The West China Hospital radiographic classification for fibrous dysplasia in femur and adjacent bones: A retrospective analysis of 205 patients.

Authors:  Yitian Wang; Yi Luo; Li Min; Yong Zhou; Jie Wang; Yuqi Zhang; Minxun Lu; Hong Duan; Chongqi Tu
Journal:  Orthop Surg       Date:  2022-08-04       Impact factor: 2.279

6.  Radiographic classification and treatment of fibrous dysplasia of the proximal femur: 227 femurs with a mean follow-up of 6 years.

Authors:  Xuelei Zhang; Chunyu Chen; Hong Duan; Chongqi Tu
Journal:  J Orthop Surg Res       Date:  2015-11-16       Impact factor: 2.359

7.  Treatment of shepherd's crook deformity in patients with polyostotic fibrous dysplasia using a new type of custom made retrograde intramedullary nail: a technical note.

Authors:  F Hefti; L Donnan; A H Krieg
Journal:  J Child Orthop       Date:  2017       Impact factor: 1.548

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.